Cambridgeshire, UK, Dec. 13, 2004 (PRIMEZONE) --
Press Release 21 October 2004
BioProgress plc
CORRECTION - Exercise of options by director
BioProgress plc, a provider of innovative delivery mechanisms for the pharmaceutical oral dosage markets, advises that further to the announcement on 18 October 2004 about the sale of ordinary shares by Graham Hind, 100,000 ordinary shares of 1p each in the capital of the Company have been issued and allotted following the exercise of 100,000 options at US$1.50 each by Graham Hind. These options had an expiry date of 31 December 2005 and not 31 December 2004 as was incorrectly advised on 18 October 2004.
Application will be made for the 100,000 new ordinary shares to be admitted to trading on the Alternative Investment Market ("AIM") of London Stock Exchange plc. Admission of the new ordinary shares is expected to become effective on 27 October 2004.
Forward-Looking Information.
The Ordinary Shares of BioProgress plc are registered under the US Securities and Exchange Act of 1934. This announcement contains certain "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. These statements are based on management's current expectations and are subject to uncertainty and changes in circumstances. Actual results may vary materially from the expectations contained in the forward-looking statements. The forward-looking statements in this release include statements addressing future financial and operating results and the timing and benefits of the reorganisation. Detailed information about factors pertinent to the business of the company that could cause actual results to differ is set forth in the Company's filings with the Securities and Exchange Commission. The Company is under no obligation to (and expressly disclaim any such obligation to) update or alter its forward-looking statements whether as a result of new information, future events or otherwise. This announcement is for information only and does not constitute an offer or invitation to acquire or dispose of any securities or investment advice. The distribution of the announcement and/or issue of securities in certain jurisdictions may be restricted by law. Persons into whose possession this announcement comes
This information is provided by RNS
The company news service from the London Stock Exchange